Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D-Reference-Cited by-同舟云学术

Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D

Published:2016-01 Issue:1 Volume:28 Page:64-69
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:European Journal of Gastroenterology & Hepatology

Author:

Patricio Jose A.,Lopes Patricia F.,Medeiros Thalia,Mendes Guilherme F.,Silva Andrea A.,Esberard Eliane B.,Lugon Jocemir R.,Almeida Jorge R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference48 articles.

1. Hepatitis B virus infection

2. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

3. Tenofovir disoproxil fumarate: A nucleotide reverse transcriptase inhibitor for the treatment of HIV infection

4. Chronic hepatitis B: Update 2009

5. Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical Markers of Calcium and Bone Metabolism during and after Lactation in Ugandan Women with HIV on Universal Maternal Antiretroviral Therapy;Journal of Bone and Mineral Research;2023-07-24

2. Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review;Frontiers in Endocrinology;2023-01-11

3. Is urinary β2-microglobulin a reliable marker for assessment of renal tubular dysfunction in chronic hepatitis B patients receiving tenofovir therapy?;European Journal of Gastroenterology & Hepatology;2020-10-29

4. Tenofovir disoproxil fumarate/emtricitabine is associated with a higher risk of hypocalcemia compared to abacavir/lamivudine – results from a German cohort study;International Journal of STD & AIDS;2019-01-10

5. Value of Cystatin C–Based e-GFR Measurements to Predict Long-Term Tenofovir Nephrotoxicity in Patients With Hepatitis B;American Journal of Therapeutics;2019-01